Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Rodin Therapeutics

Rodin Therapeutics

Rodin Therapeutics was a biotechnology company that developed treatments for Alzheimer's disease. Founded in 2013, it was acquired in 2019 by Alkermes.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
Acquirer
Alkermes (company)
Alkermes (company)
AngelList URL
angel.co/rodin-therapeutics-1
B2X
B2B
B2B
CEO
‌
Adam Rosenberg
Company Operating Status
Closed
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
Date Incorporated
2013
DUNS Number
078876254
Founded Date
2013
Founder
Ankit Mahadevia
Ankit Mahadevia
Bruce Booth
Bruce Booth
Industry
Biotechnology
Biotechnology
Neuroscience
Neuroscience
Therapeutics
Therapeutics
Epigenetics
Epigenetics
Healthcare
Healthcare
Pharmaceutical industry
Pharmaceutical industry
Technology
Technology
Biology
Biology
Investors
Third Point Ventures
Third Point Ventures
Hatteras Venture Partners
Hatteras Venture Partners
Remeditex Ventures
Remeditex Ventures
Google Ventures
Google Ventures
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation
Atlas Venture
Atlas Venture
Latest Funding Round Date
September 2017
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/rodin-therapeutics
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
Number of Employees (Ranges)
1 – 10
0
Patents Assigned (Count)
2
Total Funding Amount (USD)
39,900,000
Twitter URL
@rodintx
Official Website
rodintherapeutics.com
Wellfound ID
rodin-therapeutics-1
Wikidata ID
Q30264435

Find more companies like Rodin Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo